XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis

Shengke He, Xiujuan Zhao, Ruifang Mu, Zhongjun Pan, Jinglan Mai

Open source

DOI
10.1515/med-2024-0913
Published
2024-01-01
Container
Open Medicine
Publisher
Walter de Gruyter GmbH
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/med-2024-0913,
  title = {XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis},
  author = {Shengke He and Xiujuan Zhao and Ruifang Mu and Zhongjun Pan and Jinglan Mai},
  year = {2024},
  journal = {Open Medicine},
  doi = {10.1515/med-2024-0913},
  url = {https://doi.org/10.1515/med-2024-0913}
}

RIS

TY  - JOUR
TI  - XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis
AU  - Shengke He
AU  - Xiujuan Zhao
AU  - Ruifang Mu
AU  - Zhongjun Pan
AU  - Jinglan Mai
PY  - 2024
JO  - Open Medicine
DO  - 10.1515/med-2024-0913
UR  - https://doi.org/10.1515/med-2024-0913
ER  - 

APA

He, S., Zhao, X., Mu, R., Pan, Z., & Mai, J. (2024). XRCC1 and hOGG1 polymorphisms and endometrial carcinoma: A meta-analysis. Open Medicine. https://doi.org/10.1515/med-2024-0913

Source records